BMPR2 and pulmonary arterial hypertension: As such, the Bone Morphogenetic Proteins (BMP) paradigm is an important clue for deciphering the pathological scenario as this pathway is downregulated in subjects carrying a heterozygous loss of function mutation of the BMP receptor type 2 gene (BMPR2) but also in BMPR2 mutation non-carrier PAH patients.